Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Oklahoma | Debridement & negative-pressure wound therapy · Alaska | |
|---|---|---|
| Surgeons, 2024 | 201 | 11 |
| Medicare fee-for-service cases | 53,727 | 2,366 |
| Growth since 2019 (Medicare FFS) | −3%/yr | −11%/yr |
| Forecast cases (Medicare FFS) | 59,200 in 2030 | 2,680 in 2030 |
| Forecast growth | +1.6%/yr to 2030 | +2.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 106.7 | 19.6 |
| Medicare Advantage share | 44% | 3% |
| Out of hospital | 40% (+7 pts since 2019) | 19% (−12 pts since 2019) |
| Cases per surgeon | 267 | 215 |
| Top 10 surgeons' share | 29% | 99% |
| Surgeons growing | 28 | 0 |
| New since the base year | 76 | 7 |
| Likely to stop billing it | 37 by 2026 | 2 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $532 | $3,931 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.